Takeda Pharmaceutical Co Ltd ADR
Price & Volume
Stats
See more52W Range | $12.99-$18.82 |
Market Cap | $58.5B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $4.4T |
Revenue Growth (YoY) | 4.2% |
Gross Profit (12 Mos) | $2.9T |
Diluted EPS | $0.22 |
News
See moreYahoo Finance • 2 days ago
Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says
Yahoo Finance • 3 days ago
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
Yahoo Finance • 4 days ago
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
Yahoo Finance • 7 days ago
Weave Bio Establishes Inaugural Strategic Advisory Board to Shape the Future of AI-Driven Regulatory Science
About
CEO | Mr. Christophe P. Weber |
CFO | Mr. Milano Furuta |
Address | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 47,455 |
